HR 1864 · in committee · significant
Risky Research Review Act
- defense
- healthcare
What this bill does
- Creates an independent board to review and approve federal funding for high-risk life sciences research that could threaten public health.
- Affects researchers, universities, and federal agencies that fund biological research on dangerous pathogens and organisms.
- Requires entities to attest to research risk levels; agencies must certify attestations and submit proposals to the board for approval.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How would the independent board's review process affect the timeline and cost for universities and researchers seeking federal funding for life sciences work?
- 02
What safeguards should exist to prevent the review board from blocking legitimate research that could advance public health or medical treatments?
- 03
Which types of pathogen research does the bill intend to regulate, and how would researchers determine whether their work requires board approval?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.

Sponsor · R-VA-9
H. Morgan Griffith
Citizen cosponsors
0
In Congress
0/ 435
House Reps cosponsoring
Introduced 2025-03-05
Legislative timeline
2025-03-05 · house · IntroReferral
Referred to the Committee on Science, Space, and Technology, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-03-05 · house · IntroReferral
Referred to the Committee on Science, Space, and Technology, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-03-05 · IntroReferral
Introduced in House
2025-03-05 · IntroReferral
Introduced in House
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.